Evidence map›Paper›PMID 30186270›Full record

ArticleFrontiers in microbiology2018

New Alpiniamides From

Constanze Paulus, Yuriy Rebets, Josef Zapp, Christian Rückert, Jörn Kalinowski, Andriy Luzhetskyy

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Evolution-guided engineering ofScience (New York, N.Y.) · 2024
    Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Constanze PaulusHelmholtz-Institute for Pharmaceutical Research Saarland, Saarbrücken, Germany.
Yuriy RebetsDepartment for Pharmaceutical Biotechnology, University of Saarland, Saarbrücken, Germany.
Josef ZappDepartment for Pharmaceutical Biotechnology, University of Saarland, Saarbrücken, Germany.
Christian RückertCenter for Biotechnology (CeBiTec), Bielefeld University, Bielefeld, Germany.
Jörn KalinowskiCenter for Biotechnology (CeBiTec), Bielefeld University, Bielefeld, Germany.
Andriy LuzhetskyyHelmholtz-Institute for Pharmaceutical Research Saarland, Saarbrücken, Germany.
Bielefeld University · DEHelmholtz Institute for Pharmaceutical Research Saarland · DESaarland University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The environment of Lake Baikal is a well-known source of microbial diversity. The strain

Indexed as

bioactivityNRPS-trans-AT-polyketide synthasesecondary metabolitesstereochemistryStreptomyces

Identifiers

PMID30186270
PMCPMC6113372
OpenAlexW2888485276

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.